Bukwang Pharm (003000) — Cash Flow Reinvestment Rate
Bukwang Pharm (003000) has a Cash Flow Reinvestment Rate of 2.10x as of June 2025, reinvesting ₩21.05 Billion (capex ₩2.80 Billion plus investments ₩-18.25 Billion) from operating cash flow of ₩10.03 Billion. See cash generation quality of Bukwang Pharm to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bukwang Pharm Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Bukwang Pharm across 10 annual periods. For the full cash flow conversion analysis, see Bukwang Pharm operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Bukwang Pharm (2007–2024)
Year-by-year capital reinvestment analysis for Bukwang Pharm. See 003000 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.17x | ₩40.11 Billion | ₩34.36 Billion | ₩2.61 Billion | ▲ +136.0% |
| 2022 | 0.49x | ₩8.14 Billion | ₩16.46 Billion | ₩4.99 Billion | ▲ +121.0% |
| 2021 | 0.22x | ₩5.94 Billion | ₩26.52 Billion | ₩785.05 Million | ▼ -96.8% |
| 2020 | 7.09x | ₩5.13 Billion | ₩723.17 Million | ₩1.92 Billion | ▲ +14.4% |
| 2018 | 6.20x | ₩42.27 Billion | ₩6.82 Billion | ₩3.71 Billion | ▲ +830.9% |
| 2017 | 0.67x | ₩5.70 Billion | ₩8.56 Billion | ₩4.49 Billion | ▼ -25.6% |
| 2015 | 0.89x | ₩9.21 Billion | ₩10.30 Billion | ₩4.58 Billion | ▲ +343.3% |
| 2014 | 0.20x | ₩5.62 Billion | ₩27.86 Billion | ₩2.97 Billion | ▼ -76.3% |
| 2013 | 0.85x | ₩31.14 Billion | ₩36.52 Billion | ₩3.74 Billion | ▲ +14.9% |
| 2007 | 0.74x | ₩20.69 Billion | ₩27.87 Billion | ₩20.69 Billion | — |